| UniProt ID | DDX42_HUMAN | |
|---|---|---|
| UniProt AC | Q86XP3 | |
| Protein Name | ATP-dependent RNA helicase DDX42 | |
| Gene Name | DDX42 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 938 | |
| Subcellular Localization | Cytoplasm. Nucleus speckle. Nucleus, Cajal body. Isoform 2 is present in Cajal bodies (CBs) and nuclear speckles. | |
| Protein Description | ATP-dependent RNA helicase. Binds to partially double-stranded RNAs (dsRNAs) in order to unwind RNA secondary structures. Unwinding is promoted in the presence of single-strand binding proteins. Mediates also RNA duplex formation thereby displacing the single-strand RNA binding protein. ATP and ADP modulate its activity: ATP binding and hydrolysis by DDX42 triggers RNA strand separation, whereas the ADP-bound form of the protein triggers annealing of complementary RNA strands. Involved in the survival of cells by interacting with TP53BP2 and thereby counteracting the apoptosis-stimulating activity of TP53BP2. Relocalizes TP53BP2 to the cytoplasm.. | |
| Protein Sequence | MNWNKGGPGTKRGFGFGGFAISAGKKEEPKLPQQSHSAFGATSSSSGFGKSAPPQLPSFYKIGSKRANFDEENAYFEDEEEDSSNVDLPYIPAENSPTRQQFHSKPVDSDSDDDPLEAFMAEVEDQAARDMKRLEEKDKERKNVKGIRDDIEEEDDQEAYFRYMAENPTAGVVQEEEEDNLEYDSDGNPIAPTKKIIDPLPPIDHSEIDYPPFEKNFYNEHEEITNLTPQQLIDLRHKLNLRVSGAAPPRPGSSFAHFGFDEQLMHQIRKSEYTQPTPIQCQGVPVALSGRDMIGIAKTGSGKTAAFIWPMLIHIMDQKELEPGDGPIAVIVCPTRELCQQIHAECKRFGKAYNLRSVAVYGGGSMWEQAKALQEGAEIVVCTPGRLIDHVKKKATNLQRVSYLVFDEADRMFDMGFEYQVRSIASHVRPDRQTLLFSATFRKKIEKLARDILIDPIRVVQGDIGEANEDVTQIVEILHSGPSKWNWLTRRLVEFTSSGSVLLFVTKKANAEELANNLKQEGHNLGLLHGDMDQSERNKVISDFKKKDIPVLVATDVAARGLDIPSIKTVINYDVARDIDTHTHRIGRTGRAGEKGVAYTLLTPKDSNFAGDLVRNLEGANQHVSKELLDLAMQNAWFRKSRFKGGKGKKLNIGGGGLGYRERPGLGSENMDRGNNNVMSNYEAYKPSTGAMGDRLTAMKAAFQSQYKSHFVAASLSNQKAGSSAAGASGWTSAGSLNSVPTNSAQQGHNSPDSPVTSAAKGIPGFGNTGNISGAPVTYPSAGAQGVNNTASGNNSREGTGGSNGKRERYTENRGSSRHSHGETGNRHSDSPRHGDGGRHGDGYRHPESSSRHTDGHRHGENRHGGSAGRHGENRGANDGRNGESRKEAFNRESKMEPKMEPKVDSSKMDKVDSKTDKTADGFAVPEPPKRKKSRWDS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MNWNKGGP -------CCCCCCCC | 13.63 | - | |
| 5 | Acetylation | ---MNWNKGGPGTKR ---CCCCCCCCCCCC | 57.78 | 19608861 | |
| 10 | Phosphorylation | WNKGGPGTKRGFGFG CCCCCCCCCCCCCCC | 22.24 | 22817900 | |
| 12 | Methylation | KGGPGTKRGFGFGGF CCCCCCCCCCCCCCE | 45.57 | 24129315 | |
| 22 | Phosphorylation | GFGGFAISAGKKEEP CCCCEEEECCCCCCC | 27.78 | 28555341 | |
| 25 | Acetylation | GFAISAGKKEEPKLP CEEEECCCCCCCCCC | 57.64 | 25953088 | |
| 26 | Acetylation | FAISAGKKEEPKLPQ EEEECCCCCCCCCCC | 67.41 | 26051181 | |
| 30 | Acetylation | AGKKEEPKLPQQSHS CCCCCCCCCCCCCCC | 75.88 | 30583609 | |
| 30 | Ubiquitination | AGKKEEPKLPQQSHS CCCCCCCCCCCCCCC | 75.88 | 29967540 | |
| 37 | Phosphorylation | KLPQQSHSAFGATSS CCCCCCCCCCCCCCC | 30.46 | 28555341 | |
| 42 | Phosphorylation | SHSAFGATSSSSGFG CCCCCCCCCCCCCCC | 29.53 | 28555341 | |
| 43 | O-linked_Glycosylation | HSAFGATSSSSGFGK CCCCCCCCCCCCCCC | 27.91 | 30059200 | |
| 43 | Phosphorylation | HSAFGATSSSSGFGK CCCCCCCCCCCCCCC | 27.91 | 28555341 | |
| 44 | Phosphorylation | SAFGATSSSSGFGKS CCCCCCCCCCCCCCC | 24.94 | 25627689 | |
| 45 | Phosphorylation | AFGATSSSSGFGKSA CCCCCCCCCCCCCCC | 33.96 | 25627689 | |
| 46 | Phosphorylation | FGATSSSSGFGKSAP CCCCCCCCCCCCCCC | 39.84 | 28555341 | |
| 50 | Acetylation | SSSSGFGKSAPPQLP CCCCCCCCCCCCCCC | 40.98 | 26051181 | |
| 50 | Methylation | SSSSGFGKSAPPQLP CCCCCCCCCCCCCCC | 40.98 | - | |
| 51 | Phosphorylation | SSSGFGKSAPPQLPS CCCCCCCCCCCCCCC | 46.52 | 23186163 | |
| 58 | Phosphorylation | SAPPQLPSFYKIGSK CCCCCCCCCEEECCC | 50.21 | 23917254 | |
| 60 | Phosphorylation | PPQLPSFYKIGSKRA CCCCCCCEEECCCCC | 13.16 | 27080861 | |
| 75 | Phosphorylation | NFDEENAYFEDEEED CCCHHHCCCCCCCCC | 21.05 | 30576142 | |
| 83 | Phosphorylation | FEDEEEDSSNVDLPY CCCCCCCCCCCCCCC | 27.39 | 30266825 | |
| 84 | Phosphorylation | EDEEEDSSNVDLPYI CCCCCCCCCCCCCCC | 53.87 | 30266825 | |
| 90 | Phosphorylation | SSNVDLPYIPAENSP CCCCCCCCCCCCCCC | 27.17 | 30266825 | |
| 96 | Phosphorylation | PYIPAENSPTRQQFH CCCCCCCCCCCHHHC | 21.10 | 25159151 | |
| 98 | Phosphorylation | IPAENSPTRQQFHSK CCCCCCCCCHHHCCC | 40.71 | 30266825 | |
| 104 | Phosphorylation | PTRQQFHSKPVDSDS CCCHHHCCCCCCCCC | 39.69 | 21955146 | |
| 109 | Phosphorylation | FHSKPVDSDSDDDPL HCCCCCCCCCCCCHH | 38.97 | 25159151 | |
| 111 | Phosphorylation | SKPVDSDSDDDPLEA CCCCCCCCCCCHHHH | 47.06 | 25159151 | |
| 145 | Acetylation | DKERKNVKGIRDDIE HHHHHCCCCCCCCCC | 59.00 | 23236377 | |
| 160 | Phosphorylation | EEDDQEAYFRYMAEN CCCCHHHHHHHHHHC | 6.45 | 22817900 | |
| 163 | Phosphorylation | DQEAYFRYMAENPTA CHHHHHHHHHHCCCC | 7.26 | 23927012 | |
| 169 | Phosphorylation | RYMAENPTAGVVQEE HHHHHCCCCCCCCCH | 47.85 | 30266825 | |
| 183 | Phosphorylation | EEEDNLEYDSDGNPI HHCCCCCCCCCCCCC | 24.74 | 29255136 | |
| 185 | Phosphorylation | EDNLEYDSDGNPIAP CCCCCCCCCCCCCCC | 46.66 | 29255136 | |
| 193 | Phosphorylation | DGNPIAPTKKIIDPL CCCCCCCCCCCCCCC | 35.63 | 30266825 | |
| 195 | Ubiquitination | NPIAPTKKIIDPLPP CCCCCCCCCCCCCCC | 47.58 | 29967540 | |
| 206 | Phosphorylation | PLPPIDHSEIDYPPF CCCCCCHHHCCCCCC | 32.28 | 24247654 | |
| 210 | Phosphorylation | IDHSEIDYPPFEKNF CCHHHCCCCCCCCCC | 20.61 | 20873877 | |
| 215 | Ubiquitination | IDYPPFEKNFYNEHE CCCCCCCCCCCCCCH | 53.38 | 29967540 | |
| 225 | Phosphorylation | YNEHEEITNLTPQQL CCCCHHHHCCCHHHH | 27.70 | 27732954 | |
| 228 | Phosphorylation | HEEITNLTPQQLIDL CHHHHCCCHHHHHHH | 22.56 | 25159151 | |
| 270 | Sumoylation | QLMHQIRKSEYTQPT HHHHHHHHCCCCCCC | 49.63 | - | |
| 270 | Acetylation | QLMHQIRKSEYTQPT HHHHHHHHCCCCCCC | 49.63 | 26051181 | |
| 270 | Malonylation | QLMHQIRKSEYTQPT HHHHHHHHCCCCCCC | 49.63 | 26320211 | |
| 270 | Sumoylation | QLMHQIRKSEYTQPT HHHHHHHHCCCCCCC | 49.63 | - | |
| 270 | Ubiquitination | QLMHQIRKSEYTQPT HHHHHHHHCCCCCCC | 49.63 | 29967540 | |
| 271 | Phosphorylation | LMHQIRKSEYTQPTP HHHHHHHCCCCCCCC | 26.45 | 28152594 | |
| 273 | Phosphorylation | HQIRKSEYTQPTPIQ HHHHHCCCCCCCCCE | 20.12 | 28152594 | |
| 274 | Phosphorylation | QIRKSEYTQPTPIQC HHHHCCCCCCCCCEE | 24.83 | 28152594 | |
| 277 | Phosphorylation | KSEYTQPTPIQCQGV HCCCCCCCCCEECCE | 24.17 | 28152594 | |
| 298 | 2-Hydroxyisobutyrylation | RDMIGIAKTGSGKTA CCEEEEEECCCCHHH | 52.04 | - | |
| 298 | Acetylation | RDMIGIAKTGSGKTA CCEEEEEECCCCHHH | 52.04 | 25953088 | |
| 298 | Ubiquitination | RDMIGIAKTGSGKTA CCEEEEEECCCCHHH | 52.04 | - | |
| 341 | Ubiquitination | PTRELCQQIHAECKR CHHHHHHHHHHHHHH | 28.56 | 24816145 | |
| 347 | Acetylation | QQIHAECKRFGKAYN HHHHHHHHHHCHHCC | 42.12 | 25953088 | |
| 351 | Acetylation | AECKRFGKAYNLRSV HHHHHHCHHCCCCEE | 45.01 | 26051181 | |
| 383 | Phosphorylation | GAEIVVCTPGRLIDH CCEEEEECCCHHHHH | 19.71 | 27690223 | |
| 392 | 2-Hydroxyisobutyrylation | GRLIDHVKKKATNLQ CHHHHHHHHHCCCCC | 45.17 | - | |
| 422 | Ubiquitination | MGFEYQVRSIASHVR CCCHHHHHHHHHHCC | 13.56 | 24816145 | |
| 442 | Ubiquitination | LLFSATFRKKIEKLA EEEEHHHHHHHHHHH | 34.70 | 24816145 | |
| 519 | Acetylation | EELANNLKQEGHNLG HHHHHHHHHHCCCHH | 48.72 | 26051181 | |
| 523 | Ubiquitination | NNLKQEGHNLGLLHG HHHHHHCCCHHCCCC | 26.11 | 24816145 | |
| 545 | 2-Hydroxyisobutyrylation | NKVISDFKKKDIPVL HHHHHHHHHCCCCEE | 65.00 | - | |
| 545 | Acetylation | NKVISDFKKKDIPVL HHHHHHHHHCCCCEE | 65.00 | 25953088 | |
| 555 | Phosphorylation | DIPVLVATDVAARGL CCCEEEEECHHHCCC | 24.43 | 21406692 | |
| 566 | Phosphorylation | ARGLDIPSIKTVINY HCCCCCCCCCEEEEH | 36.73 | 24719451 | |
| 581 | Phosphorylation | DVARDIDTHTHRIGR HHHCCCCCCCCCCCC | 29.07 | 20068231 | |
| 583 | Phosphorylation | ARDIDTHTHRIGRTG HCCCCCCCCCCCCCC | 18.23 | 20068231 | |
| 599 | Phosphorylation | AGEKGVAYTLLTPKD CCCCCEEEEEECCCC | 8.77 | 28152594 | |
| 600 | Phosphorylation | GEKGVAYTLLTPKDS CCCCEEEEEECCCCC | 12.93 | 28152594 | |
| 603 | Phosphorylation | GVAYTLLTPKDSNFA CEEEEEECCCCCCCC | 31.25 | 28857561 | |
| 605 | Ubiquitination | AYTLLTPKDSNFAGD EEEEECCCCCCCCHH | 69.43 | 24816145 | |
| 626 | Acetylation | GANQHVSKELLDLAM HHHHHHCHHHHHHHH | 51.82 | 7713437 | |
| 668 | Phosphorylation | RERPGLGSENMDRGN CCCCCCCCCCCCCCC | 30.73 | 20873877 | |
| 671 | Sulfoxidation | PGLGSENMDRGNNNV CCCCCCCCCCCCCCC | 3.05 | 21406390 | |
| 673 | Methylation | LGSENMDRGNNNVMS CCCCCCCCCCCCCCC | 38.68 | - | |
| 680 | Phosphorylation | RGNNNVMSNYEAYKP CCCCCCCCCCEECCC | 31.79 | 22210691 | |
| 682 | Phosphorylation | NNNVMSNYEAYKPST CCCCCCCCEECCCCC | 8.47 | 21945579 | |
| 685 | Phosphorylation | VMSNYEAYKPSTGAM CCCCCEECCCCCCCC | 16.11 | 22210691 | |
| 686 | Acetylation | MSNYEAYKPSTGAMG CCCCEECCCCCCCCH | 39.27 | 23954790 | |
| 686 | Ubiquitination | MSNYEAYKPSTGAMG CCCCEECCCCCCCCH | 39.27 | 24816145 | |
| 688 | Phosphorylation | NYEAYKPSTGAMGDR CCEECCCCCCCCHHH | 35.01 | 21945579 | |
| 689 | Phosphorylation | YEAYKPSTGAMGDRL CEECCCCCCCCHHHH | 37.17 | 21945579 | |
| 700 | Acetylation | GDRLTAMKAAFQSQY HHHHHHHHHHHHHHH | 33.81 | 25953088 | |
| 700 | Methylation | GDRLTAMKAAFQSQY HHHHHHHHHHHHHHH | 33.81 | - | |
| 700 | Ubiquitination | GDRLTAMKAAFQSQY HHHHHHHHHHHHHHH | 33.81 | 32015554 | |
| 705 | Phosphorylation | AMKAAFQSQYKSHFV HHHHHHHHHHHHHHH | 29.08 | 25159151 | |
| 707 | Phosphorylation | KAAFQSQYKSHFVAA HHHHHHHHHHHHHHH | 21.50 | - | |
| 708 | Methylation | AAFQSQYKSHFVAAS HHHHHHHHHHHHHHH | 29.80 | 24129315 | |
| 715 | O-linked_Glycosylation | KSHFVAASLSNQKAG HHHHHHHHHCCCCCC | 23.69 | 30059200 | |
| 715 | Phosphorylation | KSHFVAASLSNQKAG HHHHHHHHHCCCCCC | 23.69 | 28450419 | |
| 717 | Phosphorylation | HFVAASLSNQKAGSS HHHHHHHCCCCCCCC | 34.42 | 28450419 | |
| 723 | Phosphorylation | LSNQKAGSSAAGASG HCCCCCCCCCCCCCC | 22.97 | 23927012 | |
| 724 | Phosphorylation | SNQKAGSSAAGASGW CCCCCCCCCCCCCCC | 22.63 | 23927012 | |
| 729 | Phosphorylation | GSSAAGASGWTSAGS CCCCCCCCCCCCCCC | 33.67 | 23927012 | |
| 732 | Phosphorylation | AAGASGWTSAGSLNS CCCCCCCCCCCCCCC | 16.54 | 23927012 | |
| 733 | Phosphorylation | AGASGWTSAGSLNSV CCCCCCCCCCCCCCC | 24.91 | 23927012 | |
| 736 | Phosphorylation | SGWTSAGSLNSVPTN CCCCCCCCCCCCCCC | 24.88 | 23927012 | |
| 739 | Phosphorylation | TSAGSLNSVPTNSAQ CCCCCCCCCCCCCCC | 34.46 | 23927012 | |
| 742 | Phosphorylation | GSLNSVPTNSAQQGH CCCCCCCCCCCCCCC | 39.38 | 23401153 | |
| 744 | Phosphorylation | LNSVPTNSAQQGHNS CCCCCCCCCCCCCCC | 29.90 | 30278072 | |
| 751 | Phosphorylation | SAQQGHNSPDSPVTS CCCCCCCCCCCCCCH | 25.14 | 25159151 | |
| 754 | Phosphorylation | QGHNSPDSPVTSAAK CCCCCCCCCCCHHHC | 25.34 | 25159151 | |
| 757 | Phosphorylation | NSPDSPVTSAAKGIP CCCCCCCCHHHCCCC | 18.94 | 30278072 | |
| 758 | Phosphorylation | SPDSPVTSAAKGIPG CCCCCCCHHHCCCCC | 26.85 | 30278072 | |
| 773 | Phosphorylation | FGNTGNISGAPVTYP CCCCCCCCCCCCCCC | 32.66 | 28555341 | |
| 792 | Phosphorylation | QGVNNTASGNNSREG CCCCCCCCCCCCCCC | 39.76 | 28555341 | |
| 806 | Acetylation | GTGGSNGKRERYTEN CCCCCCCCHHCCCCC | 56.17 | 15615005 | |
| 810 | Phosphorylation | SNGKRERYTENRGSS CCCCHHCCCCCCCCC | 17.41 | 21888424 | |
| 814 | Methylation | RERYTENRGSSRHSH HHCCCCCCCCCCCCC | 39.89 | - | |
| 817 | Phosphorylation | YTENRGSSRHSHGET CCCCCCCCCCCCCCC | 36.52 | 21888424 | |
| 820 | Phosphorylation | NRGSSRHSHGETGNR CCCCCCCCCCCCCCC | 31.88 | - | |
| 829 | Phosphorylation | GETGNRHSDSPRHGD CCCCCCCCCCCCCCC | 36.22 | 26699800 | |
| 831 | Phosphorylation | TGNRHSDSPRHGDGG CCCCCCCCCCCCCCC | 27.18 | 30576142 | |
| 844 | Phosphorylation | GGRHGDGYRHPESSS CCCCCCCCCCCCCCC | 15.53 | - | |
| 850 | Phosphorylation | GYRHPESSSRHTDGH CCCCCCCCCCCCCCC | 29.72 | 30576142 | |
| 851 | Phosphorylation | YRHPESSSRHTDGHR CCCCCCCCCCCCCCC | 37.04 | 30576142 | |
| 875 | Methylation | AGRHGENRGANDGRN CCCCCCCCCCCCCCC | 41.10 | - | |
| 894 | Phosphorylation | KEAFNRESKMEPKME HHHHHHHHCCCCCCC | 33.78 | 23917254 | |
| 899 | Sumoylation | RESKMEPKMEPKVDS HHHCCCCCCCCCCCH | 42.46 | - | |
| 899 | Sumoylation | RESKMEPKMEPKVDS HHHCCCCCCCCCCCH | 42.46 | 28112733 | |
| 906 | Phosphorylation | KMEPKVDSSKMDKVD CCCCCCCHHHHCCCC | 34.54 | 28258704 | |
| 907 | Phosphorylation | MEPKVDSSKMDKVDS CCCCCCHHHHCCCCC | 27.77 | 28258704 | |
| 914 | Phosphorylation | SKMDKVDSKTDKTAD HHHCCCCCCCCCCCC | 40.20 | - | |
| 918 | Acetylation | KVDSKTDKTADGFAV CCCCCCCCCCCCCCC | 51.34 | 26051181 | |
| 938 | Acetylation | RKKSRWDS------- CCCCCCCC------- | 34.85 | 19608861 | |
| 938 | Phosphorylation | RKKSRWDS------- CCCCCCCC------- | 34.85 | 24719451 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DDX42_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DDX42_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DDX42_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| A4_HUMAN | APP | physical | 21832049 | |
| TCRG1_HUMAN | TCERG1 | physical | 22939629 | |
| HNRPQ_HUMAN | SYNCRIP | physical | 22939629 | |
| KS6A4_HUMAN | RPS6KA4 | physical | 22939629 | |
| RL36_HUMAN | RPL36 | physical | 22939629 | |
| PIN4_HUMAN | PIN4 | physical | 22939629 | |
| PHF20_HUMAN | PHF20 | physical | 22939629 | |
| KALM_HUMAN | KAL1 | physical | 22939629 | |
| NOSIP_HUMAN | NOSIP | physical | 22939629 | |
| SYEP_HUMAN | EPRS | physical | 22939629 | |
| FOXJ3_HUMAN | FOXJ3 | physical | 22939629 | |
| RU1C_HUMAN | SNRPC | physical | 22365833 | |
| SF3A1_HUMAN | SF3A1 | physical | 22365833 | |
| SF3B4_HUMAN | SF3B4 | physical | 22365833 | |
| DHX15_HUMAN | DHX15 | physical | 22365833 | |
| SR140_HUMAN | U2SURP | physical | 22365833 | |
| PRP19_HUMAN | PRPF19 | physical | 22365833 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND LYS-5, AND MASSSPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-109 AND SER-111, ANDMASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-185; SER-751 ANDSER-754, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-104; SER-109; SER-111;SER-185 AND SER-754, AND MASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-10; SER-96; SER-109 ANDSER-111, AND MASS SPECTROMETRY. | |